Publication: 4300

Publication: 4300

Different prognostic values of KRAS exon 2 submutations and BRAF V600E mutation in microsatellite stable (MSS) and unstable (MSI) stage III colon cancer: an ACCENT/IDEA pooled analysis of seven trials.

PubMed

DOI

Google Scholar

Citation:: Ann Oncol vol 34 (11) 1025-34

Year:: 2023
Type:: Manuscript
Funding:: Not Funded
Endpoint:: Secondary-not-in-original
Analysis:: Meta-Analysis
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: No
SDC:: Yes
Book Volume:

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: GI
Sec. Committees:

Pharmas:
Grants:

Corr. Author:
Authors:: J Taieb F A Sinicrope L Pederson S Lonardi S R Alberts T J George G Yothers E Van Cutsem L Saltz S Ogino R Kerr T Yoshino R M Goldberg T André P Laurent-Puig Q Shi

Networks:

Study
Multiple Studies, or Legacy Studies in Alliance Study:: ACCENT, IDEA
Phases:: N/A

Keywords:: BRAF(V600E) mutation, MSI/dMMR, RAS mutation, adjuvant, stage III colon cancer, survival after relapse, time to recurrence